Norepinephrine vs Nitric Oxide Synthase Inhibition in Endotoxemia

  • Klaus Wagner
  • Reiner Schäfer
  • Angela Roth-Isigkeit
  • Karl-F. Klotz
  • Hans-Jürgen Friedrich
  • Peter Schmucker
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 471)

Abstract

The mortality rate in sepsis reemains high despite many therapeutic efforts. Initial treatment of sepsis, in addition to surgical treatment of the underlying cause, is aimed to prevent circulatory shock leading to multiple organ failure, including liver failure. Therefore, vasopressor agents such as norepinephrine (NE) are frequently administered to restore vascular tone and improve tissue perfusion (Vincent et al., 1991).

Keywords

Catheter Lactate Norepinephrine Fentanyl Ketamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Antonsson Jan B, Kari Kutilla, Juha Niinikoski, and Ulf Hagrund: Subcaneous and gut tissue perfusion and oxygenation changes as related to oxygen transport in experimental peritonitis. Circ Shock 1993;41:261–267.PubMedGoogle Scholar
  2. Arvidsson D, Rasmussen I, Almqvist P, Niklasson F, and Haglung U: Splanchnic oxygen consumption in septic and hemorrhagic shock. Surgery 1991; 109:190–197.PubMedGoogle Scholar
  3. Breslow MJ, Miller CF, Parker SD, Walmanet AT, and Traystman RJ: Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 1987;252:H291–H300.PubMedGoogle Scholar
  4. Burton RG and Gorewit RC: Ultrasonic flowmeter uses wide-beam transit-time technique. Med Elec 1984; 34:68–73.Google Scholar
  5. Curtis SE and Cain SM: Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Am Rev Respir Dis 1992; 145:348–354.PubMedGoogle Scholar
  6. Dahn MS, Wilson RF, Lange MP, Stone A, and Jacobs LA: Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 1990;125:441–443.PubMedCrossRefGoogle Scholar
  7. Evans TE, Carpenter A, Kinderman H, and Cohen J: Evidence of increased nitric oxide production in patients with the sepsis sydrome. Circulatory Shock 1993;41:77–81.PubMedGoogle Scholar
  8. Fink MP, Rothschild HR, Deniz YF, Wang H, Lee PC, and Cohn SM: Systemic and mesenteric O2-metabolism in endotoxic pigs: effect of ibuprofen and meclofenamate. J Appl Physiol 1989; 67:1950–1957.PubMedGoogle Scholar
  9. Hurtado FJ, Gutierrez AM, Silva N, Fernandez E, Khan AE, and Gutierrez G: Role of tissue hypoxia as the mechanism of lactic acidosis during E. coli endotoxemia. J Appl Physiol 1992; 72:1895–1901.PubMedGoogle Scholar
  10. Kessler M, Höper J, and Krumme BA: Monitoring of tissue perfusion and cellular function. Anesthesiology 1976; 45:184–197.PubMedCrossRefGoogle Scholar
  11. Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, and Lodato RF: Reversal of endotoxin-mediated shock by B-methyl-1-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:l 132–1138.Google Scholar
  12. Klabunde RE and Ritger RC: NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardic output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991;178:1135–1140.PubMedCrossRefGoogle Scholar
  13. Lang Ch, Bagby GJ, Ferguson JL, and Spitzer JJ: Cardiac output and redistribution of organ blood flow in hypermetabolic sepaia. Am J Physiol 1984; 246:331–337.Google Scholar
  14. Lorente J, Landin L, Renes E, de Pablo R, Jorge P, Rodena E, and Liste D: Role of nitric oxide in the hemo-dynamic changes of sepsis, Crit Care Med 1993; 21:759–767.PubMedCrossRefGoogle Scholar
  15. Mäkisalo HJ, Soini HO, Lalla MLT, and Höckerstedt KAV: Subcutaneous and liver tissue oxygen tension in hemorrhagic shock: an experimental study with whole blood and two colloids. Crit Care Med 1988;16:857–861.PubMedCrossRefGoogle Scholar
  16. Meadows D, Edwards JD, Wilkins RG, and Nightingale P: Reversal of intractable septic shock with norepi-nephrine therapy, Crit Care Med 1988; 16:124–132.CrossRefGoogle Scholar
  17. Meyer J, Hinder F, Stothert Jr. J, Traber LD, Herndon DN, Flynn JT, and Traber DL: Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 1994; 76:2785–2793.PubMedGoogle Scholar
  18. Moncada S, Palmer RMJ, and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109–142.PubMedGoogle Scholar
  19. Nöldge GFE, Priebe H-J, and Geiger K: Splanchnic hemodynamics and oxygen supply during acute normovolemic hemodilution alone and with isoflurane-induced hypotension in the anaesthetized pig. Anesth Analg 1992; 75:660–674.PubMedGoogle Scholar
  20. Nöldge GFE, Pannen BHJ, Armbruster K, and Gelger KK: Endotoxemia induces more profound impairment of small intestinal than of hepatic oxygenation in pigs. Anaesthesiology 1993; 79:A253.Google Scholar
  21. Nöldge GFE, Armbruster K, Pannen BHJ, Müller W, and Gelger KK: Changes in intestinal mucosal pH during endotoxemia are not necessarily reflected in respective changes in splanchnic metabolic and acid-base status. Anaesthesiology 1993; 79:A761.Google Scholar
  22. Ottosson J, Dawidson I, Brandberg A, Idvall J, and Sandor Z: Cardiac output and organ blood flow in experimental septic shock: effect of treatment with antibiotics, corticosteroids, and fluid infusion, Circulatory Shock 1991; 35:14–24.PubMedGoogle Scholar
  23. Petros AJ, Lamb G, Leone A, Moncada S, Bennett D, and Vallance P: Effect of a nitric oxide synthase inhibitor in patients with septic shock: a randomised study. Cardiovascular Research 1994; 28:34–39.PubMedCrossRefGoogle Scholar
  24. Pizcueta P, Piqué JM, Fernandez M, Bosch J, Rodés J, Whittle BJR, and Moncada S: Modulation of the hyper-dynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103:1909–1915.PubMedGoogle Scholar
  25. Pohl U, Wagner K, and De Witt C: Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. Europ Heart J 1993;14(S I):93–98.Google Scholar
  26. Schneider F, Lutun P, Vouchot A, Bilbault P, and Tempe JD: Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 1993;19:99–104.PubMedCrossRefGoogle Scholar
  27. Schramm U, Wagner K, Bossen W, and Weiss C: PO2 Messung mit einem neuen Sauerstoffsensor: Morphologische Veränderungen im Bereich des Stichkanals. Anat Anz 1992; 174:78–81.Google Scholar
  28. Vaupel P, Schienger K, Knoop C, and Höckel M: Oxygenation of human tumors:evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991; 51:3316–3322.PubMedGoogle Scholar
  29. Vincent JL: Diagnostic and medical management/supportive care of patients with gram-negative bacteremia and septic shock. Infect Dis Clin North Am 1991; 5:807–816.PubMedGoogle Scholar
  30. Wagner K, Bossen W, and Schramm U: Tissue alterations by the penetration of a pO2 sensing needle. Adv Exp Med Biol 1992; 317:639–644.PubMedCrossRefGoogle Scholar
  31. Wang P, Ba ZF, and Chaudry IH: Increase of hepatic blood flow during early sepsis is due to increased portal blood flow. Am J Physiol 1991; 261:R1507–R1512.PubMedGoogle Scholar
  32. Wright CE, Rees DD, and Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48–57.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Klaus Wagner
    • 1
  • Reiner Schäfer
    • 1
  • Angela Roth-Isigkeit
    • 2
  • Karl-F. Klotz
    • 1
  • Hans-Jürgen Friedrich
    • 2
  • Peter Schmucker
    • 2
  1. 1.Department of AnesthesiologyMedical University LübeckGermany
  2. 2.Institut für medizinische Biometrie und StatistikMedical University LübeckGermany

Personalised recommendations